Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
60 participants
OBSERVATIONAL
2024-03-01
2025-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Detailed history: including history of medical comorbidities, previous history of stone disease or previous treatment of renal stones.
Complete physical examination with measurement and documentation of the pre-operative blood pressure for all patients.
Estimation of body mass index (BMI).
Pre-operative laboratory investigations including:
Complete urine analysis Urine culture and sensitivity test Complete blood picture (CBC). Prothrombin time and prothrombin concentration. Serum urea and creatinine Random blood sugar -Pre-operative imaging investigations: Plain KUB( Number, site, size and radio-opacity of Stones) Abdominal ultrasound ( Dimensions, Shape, borders, contour, orientation \& echogenicity, hydronephrosis, stones \& others eg. Cysts) Multi-slice computed tomography (MSCT) abdomen and pelvis without contrast. (Dimensions, Shape, borders, contour, orientation, number, site, size, laterality and density of stones) Color Doppler Ultrasonography ( Renal arteries caliber, outline, resistive index, intrarenal arterial waveforms acceleration time\& peak systolic velocity) Radioisotope scan (DMSA scan)
-Procedural steps and techniques: Patients with urinary tract infections will be treated with the appropriate antibiotics according to urine culture and sensitivity test until negative culture is obtained.
Percutaneous nephrolithotomy (PCNL) will be performed in prone/supine position under general or spinal anesthesia after insertion of a ureteral catheter to the affected site.
Access will be done under fluoroscopic guidance. Tract dilatation will be done by using either balloon dilator or Amplatz teflon dilators then Amplatz will be inserted.
Stone disintegration after well established track will be done by using either pneumatic or ultrasonic or laser lithotripters.
Stone retrieval will be done by either forceps or Zero-tip dormia basket. At the end of the procedure, plastic tube 22 French may be inserted through the Amplatz sheath as nephrostomy tube or not (tubeless).
Intraoperatively: we record operative time, anaesthesia time, site of renal puncture, puncture relation to last rib, dilatation method, teflon dilatation steps, number of accesses, disintegration methods, use of flexible nephroscope, intraoperative blood transfusion, nephrostomy tube, state of nephrostomy tube when open and perioperative complications.
Post-operative care and follow up:
Plain KUB, abdominal ultrasound, CBC, prothrombin time and concentration \& serum creatinine will be done at Day 1 postoperatively.
Measurement of blood pressure at day 1 postoperatively. Abdominal ultrasonography\&Color Doppler Ultrasonography at Day 1, Day 7 and Day 90 postoperatively.
Radioisotope scan (DMSA scan) at day 90 postoperatively. Urine analysis
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Patients with malrotated/anomalous kidney.
3. Patients with any grade of chronic kidney disease.
4. Patients with bleeding diathesis.
5. Patients who are unfit for surgery.
6. Pregnancy
7. Patients who are refusing the participation in our study.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Walid Atef Abdulmonem Abdulhafez
Assistant lecturer
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Percutaneous*Nephrolithotomy
Identifier Type: -
Identifier Source: org_study_id